Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.68
Price to sales ratio
5.13

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2007
PGNY
Progyny, Inc. - Common Stock
26.00 USD+0.54%+1.36%-16.13%+32.92%1.99 B USD
2186
OMCL
Omnicell, Inc. - Common Stock
33.08 USD-0.99%-7.03%-6.82%+6.13%1.51 B USD
2308
CERT
Certara, Inc. - Common Stock
8.35 USD-0.71%-0.95%+5.70%-22.04%1.27 B USD
2340
GDRX
GoodRx Holdings, Inc. - Class A Common Stock
3.53 USD+0.57%+2.62%+9.63%-16.94%1.20 B USD

Frequently asked questions about Schrodinger, Inc. Common Stock

What is the Schrodinger, Inc. Common Stock stock price today?

The current price of Schrodinger, Inc. Common Stock (SDGR) is 19.70. Over the past 24 hours, the stock has changed by -3.48%. Follow the SDGR chart for real-time price dynamics.

What is the stock ticker of Schrodinger, Inc. Common Stock?

Schrodinger, Inc. Common Stock trades under the ticker SDGR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Schrodinger, Inc. Common Stock stock going up?

SDGR has changed by +0.46% over the last week, +30.98% over the last month, and +2.23% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Schrodinger, Inc. Common Stock?

Schrodinger, Inc. Common Stock currently has a market capitalization of 1.47 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Schrodinger, Inc. Common Stock earnings last quarter?

Last quarter, Schrodinger, Inc. Common Stock reported earnings of 0.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Schrodinger, Inc. Common Stock revenue for the last quarter?

Schrodinger, Inc. Common Stock reported quarterly revenue of 58.89 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Schrodinger, Inc. Common Stock net income for the last quarter?

Schrodinger, Inc. Common Stock reported net income of 5.97 M for the last quarter. The previous quarter showed -60.03 M, which means net income changed by +109.95%.

How many employees does Schrodinger, Inc. Common Stock have?

As of the latest available data, Schrodinger, Inc. Common Stock has 850 employees. Workforce size can provide additional context about the company's scale and operations.

What is Schrodinger, Inc. Common Stock EBITDA?

Schrodinger, Inc. Common Stock EBITDA is -40.06 M, and its EBITDA margin is -68.02%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Schrodinger, Inc. Common Stock stock?

You can buy Schrodinger, Inc. Common Stock (SDGR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Schrodinger, Inc. Common Stock stock?

Investing in Schrodinger, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SDGR chart and related analysis on metatrader.com as part of your research.

Schrodinger, Inc. - Common Stock

Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery.

News